肝再生
再生(生物学)
医学
再生医学
肝移植
肝功能
肝病
中医药
生物信息学
药理学
移植
病理
生物
干细胞
外科
内科学
替代医学
细胞生物学
作者
Jiating Ma,Shuang Xia,Bikui Zhang,Fen Luo,Lin Guo,Yan Yang,Hui Gong,Miao Yan
出处
期刊:Phytomedicine
[Elsevier BV]
日期:2023-05-18
卷期号:116: 154893-154893
被引量:6
标识
DOI:10.1016/j.phymed.2023.154893
摘要
The liver is renowned for its remarkable regenerative capacity to restore its structure, size and function after various types of liver injury. However, in patients with end-stage liver disease, the regenerative capacity is inhibited and liver transplantation is the only option. Considering the limitations of liver transplantation, promoting liver regeneration is suggested as a new therapeutic strategy for liver disease. Traditional Chinese medicine (TCM) has a long history of preventing and treating various liver diseases, and some of them have been proven to be effective in promoting liver regeneration, suggesting the therapeutic potential in liver diseases. This review aims to summarize the molecular mechanisms of liver regeneration and the pro-regenerative activity and mechanism of TCM formulas, extracts and active ingredients. We conducted a systematic search in PubMed, Web of Science and the Cochrane Library databases using "TCM", "liver regeneration" or their synonyms as keywords, and classified and summarized the retrieved literature. The PRISMA guidelines were followed. Forty-one research articles met the themes of this review and previous critical studies were also reviewed to provide essential background information. Current evidences indicate that various TCM formulas, extracts and active ingredients have the effect on stimulating liver regeneration through modulating JAK/STAT, Hippo, P13K/Akt and other signaling pathways. Besides, the mechanisms of liver regeneration, the limitation of existing studies and the application prospect of TCM to promote liver regeneration are also outlined and discussed in this review. This review supports TCM as new potential therapeutic options for promoting liver regeneration and repair of the failing liver, although extensive pharmacokinetic and toxicological studies, as well as elaborate clinical trials, are still needed to demonstrate safety and efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI